March 7, 2019
Sawai Pharmaceutical said on March 6 that its generic version of Otsuka Pharmaceutical’s antipsychotic agent Abilify (aripiprazole) has been approved for an additional indication of depression/depressive state, together with a new dosage for the new indication. Aripiprazole Tablets and Oral...read more